Department of Medicine-Western Health, Melbourne Medical School, The University of Melbourne, Melbourne, VIC, Australia.
Australian Institute for Musculoskeletal Science (AIMSS), Geroscience & Osteosarcopenia Research Program, The University of Melbourne and Western Health, Melbourne, VIC, Australia.
J Cachexia Sarcopenia Muscle. 2021 Dec;12(6):2022-2033. doi: 10.1002/jcsm.12805. Epub 2021 Sep 14.
Increasing protein intake (above the Recommended Dietary Amount) alone or with resistance-based exercise is suggested to improve cardiometabolic health; however, randomized controlled trials (RCTs) are needed to confirm this.
The Liverpool Hope University-Sarcopenia Aging Trial (LHU-SAT) was a 16 week RCT (ClinicalTrials.gov Identifier: NCT02912130) of 100 community-dwelling older adults [mean age: 68.73 ± 5.80 years, body mass index: 27.06 ± 5.18 kg/m (52% women)] who were randomized to four independent groups [Control (C), Exercise (E), Exercise + Protein (EP), Protein (P)]. E and EP completed supervised and progressive resistance-based exercise (resistance exercise: two times per week, functional circuit exercise: once per week), while EP and P were supplemented with a leucine-enriched whey protein drink (three times per day) based on individual body weight (0.50 g/kg/meal, 1.50 g/kg/day). Outcome measures including arterial stiffness (pulse wave velocity), fasting plasma/serum biomarkers [glucose/glycated haemoglobin, total cholesterol, low-density lipoprotein (LDL), high-density lipoprotein, insulin, resistin, leptin, adiponectin, C-reactive protein, tumour necrosis factor-alpha, interleukin-6, cystatin-C, & ferritin], insulin resistance (HOMA-IR), and kidney function (eGFR) were measured before and after intervention.
Total protein intake (habitual diet plus supplementation) increased to 1.55 ± 0.69 g/kg/day in EP and to 1.93 ± 0.72 g/kg/day in P, and remained significantly lower (P < 0.001) in unsupplemented groups (E: 1.08 ± 0.33 g/kg/day, C: 1.00 ± 0.26 g/kg/day). At 16 weeks, there was a group-by-time interaction whereby absolute changes in LDL-cholesterol were lower in EP [mean difference: -0.79 mmol/L, 95% confidence interval (CI): -1.29, -0.28, P = 0.002] and P (mean difference: -0.76 mmol/L, 95% CI: -1.26, -0.26, P = 0.003) vs. C. Serum insulin also showed group-by-time interactions at 16 weeks whereby fold changes were lower in EP (mean difference: -0.40, 95% CI: -0.65, -0.16, P = 0.001) and P (mean difference: -0.32, 95% CI: -0.56, -0.08, P = 0.009) vs. C, and fold changes in HOMA-IR improved in EP (mean difference: -0.37, 95% CI: -0.64, -0.10, P = 0.007) and P (mean difference: -0.27, 95% CI: -0.53, -0.00, P = 0.048) vs. C. Serum resistin declined in P only (group-by-time interaction at 16 weeks: P = 0.009). No other interactions were observed in outcome measures (P > 0.05), and kidney function (eGFR) remained unaltered.
Sixteen weeks of leucine-enriched whey protein supplementation alone and combined with resistance-based exercise improved cardiometabolic health markers in older adults.
增加蛋白质的摄入量(超过推荐的饮食量)单独或结合抗阻运动被认为可以改善心血管代谢健康;然而,需要进行随机对照试验(RCT)来证实这一点。
利物浦霍普大学肌少症衰老试验(LHU-SAT)是一项针对 100 名社区居住的老年人的 16 周 RCT(临床试验.gov 标识符:NCT02912130),[平均年龄:68.73±5.80 岁,体重指数:27.06±5.18kg/m(52%为女性)],他们被随机分为四个独立的组[对照组(C)、运动组(E)、运动+蛋白质组(EP)、蛋白质组(P)]。E 和 EP 完成了监督和渐进性的抗阻运动(阻力运动:每周两次,功能性电路运动:每周一次),而 EP 和 P 则根据个人体重补充了富含亮氨酸的乳清蛋白饮料(每天三次)(0.50g/kg/餐,1.50g/kg/天)。在干预前后测量了动脉僵硬(脉搏波速度)、空腹血浆/血清生物标志物[血糖/糖化血红蛋白、总胆固醇、低密度脂蛋白(LDL)、高密度脂蛋白、胰岛素、抵抗素、瘦素、脂联素、C 反应蛋白、肿瘤坏死因子-α、白细胞介素-6、胱抑素-C 和铁蛋白]、胰岛素抵抗(HOMA-IR)和肾功能(eGFR)等结果指标。
EP 组的总蛋白质摄入量(习惯性饮食加补充剂)增加到 1.55±0.69g/kg/天,P 组增加到 1.93±0.72g/kg/天,而未补充组的摄入量仍显著较低(P<0.001)(E 组:1.08±0.33g/kg/天,C 组:1.00±0.26g/kg/天)。在 16 周时,存在一个组间时间的相互作用,即 EP 组 LDL 胆固醇的绝对变化较低[平均差异:-0.79mmol/L,95%置信区间(CI):-1.29,-0.28,P=0.002]和 P[平均差异:-0.76mmol/L,95%CI:-1.26,-0.26,P=0.003]与 C 相比。血清胰岛素也在 16 周时出现了组间时间的相互作用,即 EP[平均差异:-0.40,95%CI:-0.65,-0.16,P=0.001]和 P[平均差异:-0.32,95%CI:-0.56,-0.08,P=0.009]的倍数变化较低,与 C 相比,HOMA-IR 的倍数变化在 EP[平均差异:-0.37,95%CI:-0.64,-0.10,P=0.007]和 P[平均差异:-0.27,95%CI:-0.53,-0.00,P=0.048]中改善,与 C 相比。只有 P 组的血清抵抗素下降(16 周时的组间时间相互作用:P=0.009)。在其他结果指标中未观察到其他相互作用(P>0.05),肾功能(eGFR)保持不变。
16 周的富含亮氨酸的乳清蛋白补充剂单独或与抗阻运动结合使用可改善老年人的心血管代谢健康标志物。